Zopiclone and Dayvigo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zopiclone (eszopiclone) and Dayvigo (lemborexant). Common drug interactions include drug eruption among females and tremor among males.

The phase IV clinical study analyzes what interactions people have when they take Zopiclone and Dayvigo. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Zopiclone?

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 54,331 Zopiclone users. Check the latest studies of Zopiclone.

What is Dayvigo?

Dayvigo has active ingredients of lemborexant. It is often used in insomnia. eHealthMe is studying from 1,470 Dayvigo users. Check the latest studies of Dayvigo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

41 people who take Zopiclone and Dayvigo together, and have interactions are studied.

Zopiclone and Dayvigo drug interactions.

What are the common drug interactions of Zopiclone and Dayvigo, by gender? *:

female:

  1. Drug eruption (adverse drug reaction of the skin)
  2. Drug hypersensitivity
  3. Dyspnoea (difficult or laboured respiration)
  4. Fistula (an abnormal connection or passageway between two)
  5. Foot fracture
  6. Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Localised infection (infection at the single location)
  10. Neck pain

male:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Abnormal faeces (abnormal stool)
  3. Dehydration (dryness resulting from the removal of water)
  4. Depression
  5. Faeces hard
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Influenza like illness
  9. Infusion related reaction
  10. Injection site pain

What are the common drug interactions of Zopiclone and Dayvigo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pyrexia (fever)
  2. Urine output decreased
  3. White blood cell count decreased
  4. Completed suicide (act of taking one's own life)
  5. Obesity (having too much body fat)
  6. Oculogyric crisis (a spasmodic movement of the eyeballs into a fixed position due to medicine reaction)
  7. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  8. Sexually inappropriate behaviour
  9. Therapeutic response decreased (less preventive response)
  10. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

50-59:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Diabetic hyperglycaemic coma (diabetic coma occurs when blood sugar gets too high and the body becomes severely dehydrated)
  4. Drug eruption (adverse drug reaction of the skin)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Interstitial lung disease
  7. Platelet count decreased

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Cholangitis acute (rapid infection of bile duct)
  3. Blood potassium decreased
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  6. Decreased appetite
  7. Diarrhoea
  8. Dizziness
  9. Drug hypersensitivity
  10. Fistula (an abnormal connection or passageway between two)

What are the existing conditions these people have? *

  1. Sleep Disorder: 5 people, 12.20%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 5 people, 12.20%
  3. Procedural Pain: 5 people, 12.20%
  4. Depression: 5 people, 12.20%
  5. Dehydration (dryness resulting from the removal of water): 5 people, 12.20%
  6. Bipolar Disorder (mood disorder): 5 people, 12.20%
  7. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 9.76%
  8. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 9.76%
  9. Hepatocellular Carcinoma (liver cancer): 3 people, 7.32%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Zopiclone and Dayvigo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zopiclone and Dayvigo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dayvigo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dayvigo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone and lemborexant (the active ingredients of Zopiclone and Dayvigo, respectively), and Zopiclone and Dayvigo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: